CD274 and cancer: Rg3 can induce an inhibitory effect on cancer development by affecting different processes and pathways, such as metastasis, DNA damage, epigenetic modification, cancer stemness, drug resistance, PI3K/AKT signaling [22–27], but its correlation with PD-L1 is poorly understood.